Valuation: Vitrolife AB

Market Cap 12.17B 1.26B 1.1B 1.02B 936M 1.77B 121B 1.8B 4.77B 59.29B 4.72B 4.62B 204B P/E 2026 *
25.4x
P/E 2027 * 20.5x
Enterprise Value 12.72B 1.31B 1.15B 1.06B 979M 1.85B 127B 1.88B 4.99B 61.97B 4.93B 4.82B 213B EV / Sales 2026 *
3.69x
EV / Sales 2027 * 3.28x
Free-Float
54.39%
Yield 2026 *
1.2%
Yield 2027 * 1.37%
1 day-1.90%
1 week+3.33%
Current month+2.45%
1 month-1.26%
3 months-16.84%
6 months-29.38%
Current year-34.38%
1 week 85.35
Extreme 85.35
101.9
1 month 84.85
Extreme 84.85
101.9
Current year 84.6
Extreme 84.6
139.6
1 year 84.6
Extreme 84.6
153.5
3 years 84.6
Extreme 84.6
268
5 years 84.6
Extreme 84.6
585
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 52 01/08/2023
Director of Finance/CFO 55 10/10/2025
Chief Investment Officer 39 -
Director TitleAgeSince
Director/Board Member 63 19/04/2013
Chairman 70 01/08/2023
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap.
06/02/26 Buy

Chief Operating Officer

6,470 0.0048%
06/02/26 Buy

Chief Executive Officer

3,013 0.0022%
04/02/26 Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-2.60%+3.33%-35.83%-46.77% 1.3B
-5.00%-6.52%+224.43%+296.86% 20.67B
-1.10%+3.44%-39.02%-23.29% 9.85B
-2.96%-0.94%+45.89%+22.92% 7B
-1.19%+3.47%+274.52%-26.12% 5.55B
+3.43%+7.18%-14.36%-20.83% 5.23B
-8.46%+23.30%+84.85%+105.62% 4.9B
-5.64%-8.79%-45.00% - 4.66B
+1.27%+2.01%-22.43%-25.26% 4.2B
+1.21%+5.98%-14.81%-39.11% 2.72B
Average -2.03%+3.87%+45.83%+27.11% 6.61B
Weighted average by Cap. -2.80%+2.30%+91.54%+98.60%

Financials

2026 *2027 *
Net sales 3.45B 356M 312M 289M 265M 501M 34.35B 509M 1.35B 16.81B 1.34B 1.31B 57.91B 3.71B 383M 335M 310M 285M 538M 36.9B 547M 1.45B 18.06B 1.44B 1.41B 62.21B
Net income 492M 50.83M 44.55M 41.18M 37.88M 71.46M 4.9B 72.61M 193M 2.4B 191M 187M 8.26B 609M 62.82M 55.07M 50.9M 46.81M 88.33M 6.06B 89.74M 239M 2.96B 236M 231M 10.21B
Net Debt 549M 56.67M 49.67M 45.91M 42.23M 79.67M 5.46B 80.95M 215M 2.67B 213M 208M 9.21B -26.67M -2.75M -2.41M -2.23M -2.05M -3.87M -265M -3.93M -10.45M -130M -10.34M -10.11M -447M
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,103
Date Price Change Volume
20/07/26 SEK 89.90 -2.60% 136,103
17/07/26 SEK 92.30 -4.40% 242,419
16/07/26 SEK 96.55 +10.60% 677,880
15/07/26 SEK 87.30 -0.91% 155,959
14/07/26 SEK 88.10 -0.06% 114,009
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
92.30SEK
Average target price
129.60SEK
Spread / Average Target
+40.41%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VITR Stock